NASDAQ: SUNSSunrise Realty Trust Inc Stock
$10.24-0.28 (-2.66%)
Updated Jul 29, 2025
SUNS Price
$10.24
Fair Value Price
N/A
Market Cap
$137.44M
52 Week Low
$7.80
52 Week High
$15.74
P/E
10.04x
P/B
0.74x
P/S
9.38x
PEG
1.33x
Dividend Yield
7.91%
Revenue
$13.22M
Earnings
$8.21M
Gross Margin
93.8%
Operating Margin
62.05%
Profit Margin
62%
Debt to Equity
0.27
Operating Cash Flow
-$392k
Beta
0.8
Next Earnings
Aug 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SUNS Overview
Founded in 2017, Sunrise REIT has served the Canadian rental community's growing need for new property and real estate projects through impressive integrity and a commitment to delivering results with the highest quality standards. Our professional team works closely with both investors and landowners in order to come up with results that exceed expectations.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SUNS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Mortgage REIT
Industry Rating
F
SUNS
Ranked#3 of 39
Ranked#3 of 39
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.37 | C | |
| $4.59 | C | |
| $14.66 | C |
Be the first to know about important SUNS news, forecast changes, insider trades & much more!
SUNS News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SUNS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SUNS ($10.24) is trading above its intrinsic value of $8.34, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SUNS is good value based on its earnings relative to its share price (10.04x), compared to the US market average (31.93x)
P/E vs Market Valuation
SUNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SUNS due diligence checks available for Premium users.
Valuation
SUNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.04x
Industry
4.45x
Market
31.93x
SUNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SUNS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SUNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.74x
Industry
0.82x
SUNS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SUNS price to earnings growth (PEG)
For valuing profitable companies with growth potential
SUNS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
SUNS's financial health
Profit margin
Revenue
$4.6M
Net Income
$3.1M
Profit Margin
67.1%
Assets to liabilities
Assets
$234.4M
Liabilities
$49.6M
Debt to equity
0.27
SUNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$914.6k
Investing
-$95.7M
Financing
-$86.3M
SUNS vs Mortgage REIT Stocks
Sunrise Realty Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.